ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q1Scopus Q1SCImago #2,620Hybrid

Pharmaceutical Medicine

Acronym:phma
•
Identifier (ISSN):1178-2595(Print)/1179-1993(Online)
•
Publisher:Springer Nature
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
4.7↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Pharmaceutical Medicine

WoS Q1
13572.520233.120244.520254.72026
Annual Impact Factor Metric
Current (2026):4.7
Scopus SJR & RankScopus Q1
1.438
#2,620

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
34

34 papers with at least that number of citations each

WoS: ESCIQ1
Self-Citation Rate9.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
27articles/year
49.14% Gold OA•67.86% Original Research

Aims & Scope

Pharmaceutical Medicine is a specialist discipline concerned with medical aspects of the discovery, development, evaluation, registration, regulation, monitoring, marketing, distribution and pricing of medicines, drug-device and drug-diagnostic combinations. The Journal disseminates information to support the community of professionals working in these highly inter-related functions. Key areas include translational medicine, clinical trial design, pharmacovigilance, clinical toxicology, drug regulation, clinical pharmacology, biostatistics and pharmacoeconomics. The Journal includes:Overviews of contentious or emerging issues.Comprehensive narrative reviews that provide an authoritative source of information on topical issues.Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by PRISMA statement.Original research articles reporting the results of well-designed studies with a strong link to wider areas of clinical research.Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pharmaceutical Medicine may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicinePsychologyPsychiatryPharmacologyNursingPathologyBusinessEconomicsPolitical ScienceLawComputer ScienceMathematics
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q1
Rank78/356
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q2
Rank135/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.7
Articles / Year32
Total Citations3
2025
IF4.5
Articles / Year235
Total Citations130
2024
IF3.1
Articles / Year37
Total Citations203
2023
IF2.5
Articles / Year53
Total Citations684
2022
IF—
Articles / Year39
Total Citations726

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,620Scopus Q1SCImago Profile
Scopus Coverage:2000-2003, 2005, 2008-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.438

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.43

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,270 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations577
3-Year Documents114
Citable Documents102

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ1
Pharmacology (medical)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 9.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Pharmaceutical Medicine (acronym: phma, ISSN: 1178-2595) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Springer Nature in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 4.70, ranking in quartile Q1 of Web of Science (ESCI), a Scopus SJR indicator of 1.438 (Q1), an H-index of 34.

The journal enforces rigorous peer evaluation with a publication frequency of 6 issues per year, an annual output of approximately 27 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,270 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
6 issues per year
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4a20f131-338f-4cd8-aa36-b2f55ecdc737
Database Updated: 2026-09-28